Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem-like cells leading to a reduced...

by Khalid eAbubaker, Khalid eAbubaker, Rodney B Luwor, Ruth eEscalona, Orla eMcNally, Orla eMcNally, Michael A Quinn, Michael A Quinn, Erik W Thompson, Jock K Findlay, Jock K Findlay, Jock K Findlay, Nuzhat eAhmed, Nuzhat eAhmed, Nuzhat eAhmed, Nuzhat eAhmed
Published 2014-04-01